Literature DB >> 16710557

Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.

Eric Noehrenberg1.   

Abstract

Mesh:

Year:  2006        PMID: 16710557      PMCID: PMC2627348          DOI: 10.2471/blt.06.032417

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  12 in total

1.  Intellectual property and access to medicines: an analysis of legislation in Central America.

Authors:  Alejandro Cerón; Angelina Snodgrass Godoy
Journal:  Bull World Health Organ       Date:  2009-10       Impact factor: 9.408

2.  Changing drug markets under new intellectual property regimes: the view from Central America.

Authors:  Angelina Snodgrass Godoy; Alejandro Cerón
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

3.  Synthetic biology: ensuring the greatest global value.

Authors:  Aidan Hollis
Journal:  Syst Synth Biol       Date:  2013-07-17

Review 4.  Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

Authors:  Ellen 't Hoen; Jonathan Berger; Alexandra Calmy; Suerie Moon
Journal:  J Int AIDS Soc       Date:  2011-03-27       Impact factor: 6.707

5.  A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries.

Authors:  Suerie Moon; Elodie Jambert; Michelle Childs; Tido von Schoen-Angerer
Journal:  Global Health       Date:  2011-10-12       Impact factor: 4.185

6.  Management of intellectual property rights in India: An updated review.

Authors:  R Tiwari; G Tiwari; A K Rai; Birendra Srivastawa
Journal:  J Nat Sci Biol Med       Date:  2011-01

7.  Obligations of low income countries in ensuring equity in global health financing.

Authors:  John Barugahare; Reidar K Lie
Journal:  BMC Med Ethics       Date:  2015-09-08       Impact factor: 2.652

8.  Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.

Authors:  Thomas Alured Faunce; Hitoshi Nasu
Journal:  Public Health Ethics       Date:  2008-05-03       Impact factor: 1.940

9.  TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?

Authors:  Vanessa Bradford Kerry; Kelley Lee
Journal:  Global Health       Date:  2007-05-24       Impact factor: 4.185

10.  Developing global health technology standards: what can other industries teach us?

Authors:  Hassan Masum; Rebecca Lackman; Karen Bartleson
Journal:  Global Health       Date:  2013-10-17       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.